In comparison, oral supplements lose a portion of their effectiveness as they pass through the digestive system, and they can take longer to show results
L., Rrth, R., Jhund, P
2085-A NOVEL MATRICELLULAR SERUM MARKERS PREDICT LIVER FIBROSIS AND FIBROGENESIS IN PATIENTS WITH NAFLD UNDERGOING BARIATRIC SURGERY Rambabu Surabattula 1 , Pierre Bel Lassen 2,3 , Sudharani Myneni 1 , Judith Aron-Wisnewsky 2,3 , Laurent Genser 3 , Jean-Daniel Zucker 2 , Karine Clment 2,3 and Detlef Schuppan 1,4 , (1)University Medical Center Mainz, (2)Sorbonne Universit, (3)Piti-Salptrire Hospital, (4)Harvard Medical School Background: Obesity is a risk factor for NAFLD and the prevalence of NAFLD in patients eligible for bariatric surgery (BS) can reach 75% to 100%
Scientists study its effects on reducing inflammation in controlled laboratory settings